AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • November 24th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • Washington
Contract Type FiledNovember 24th, 2014 Company Industry JurisdictionThis AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (“AGREEMENT”) is made on this 2nd day of January, 2012, by and between FRED HUTCHINSON CANCER RESEARCH CENTER (“FHCRC”), a Washington state nonprofit organization, with principal offices located at 1100 Fairview Ave. N., Seattle, Washington 98109, and ZetaRx BioSciences Inc., a Delaware corporation, having a principal place of business located at 307 Westlake Avenue North, Suite 300, Seattle, WA 98109 (“LICENSEE”).
AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • November 24th, 2014 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • Washington
Contract Type FiledNovember 24th, 2014 Company Industry JurisdictionThis AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (“AGREEMENT”) is made on this 1st day of November, 2009, by and between FRED HUTCHINSON CANCER RESEARCH CENTER (“FHCRC”), a Washington state nonprofit organization, with principal offices located at 1100 Fairview Ave. N., Seattle, Washington 98109, and ZETARX LLC, a Delaware limited liability company, having a principal place of business located at 9701 Wilshire Blvd. Suite 1000, Beverly Hills, CA 90212 (“LICENSEE”).